Human adipose beiging in response to cold and mirabegron
The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. We exposed lean and obese research participants to cold (3...
Saved in:
Published in | JCI insight Vol. 3; no. 15 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Clinical Investigation
09.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.
We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.
Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.
Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.
Clinicaltrials.gov NCT02596776, NCT02919176.
NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). |
---|---|
AbstractList | The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.
We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.
Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.
Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.
Clinicaltrials.gov NCT02596776, NCT02919176.
NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.BACKGROUNDThe induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown.We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.METHODSWe exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system.Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.RESULTSCold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine660 in obese subjects.Cold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.CONCLUSIONCold or β3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals.Clinicaltrials.gov NCT02596776, NCT02919176.TRIAL REGISTRATIONClinicaltrials.gov NCT02596776, NCT02919176.NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998).FUNDINGNIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). BACKGROUND. The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The ability of obese, insulin-resistant humans to induce beige adipose tissue is unknown. METHODS. We exposed lean and obese research participants to cold (30-minute ice pack application each day for 10 days of the upper thigh) or treated them with the β 3 agonist mirabegron. We determined beige adipose marker expression by IHC and quantitative PCR, and we analyzed mitochondrial bioenergetics and UCP activity with an Oxytherm system. RESULTS. Cold significantly induced UCP1 and TMEM26 protein in both lean and obese subjects, and this response was not associated with age. Interestingly, these proteins increased to the same extent in s.c. WAT of the noniced contralateral leg, indicating a crossover effect. We further analyzed the bioenergetics of purified mitochondria from the abdominal s.c. WAT of cold-treated subjects and determined that repeat ice application significantly increased uncoupled respiration, consistent with the UCP1 protein induction and subsequent activation. Cold also increased State 3 and maximal respiration, and this effect on mitochondrial bioenergetics was stronger in summer than winter. Chronic treatment (10 weeks; 50 mg/day) with the β 3 receptor agonist mirabegron induces UCP1, TMEM26, CIDEA, and phosphorylation of HSL on serine 660 in obese subjects. CONCLUSION. Cold or β 3 agonists cause the induction of beige adipose tissue in human s.c. WAT; this phenomenon may be exploited to increase beige adipose in older, insulin-resistant, obese individuals. TRIAL REGISTRATION. Clinicaltrials.gov NCT02596776, NCT02919176. FUNDING. NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). Cold stimulates beige adipose formation equally in both lean and obese humans, and the beta3 agonist mirabegron treatment stimulates beiging in obese, insulin-resistant humans. |
Author | Westgate, Philip M. Finlin, Brian S. Kern, Philip A. Zhu, Beibei Harfmann, Brianna Johnson, Zachary R. Sullivan, Patrick G. Alexander, Caroline M. Kasza, Ildiko Confides, Amy L. Dupont-Versteegden, Esther E. Memetimin, Hasiyet Vekaria, Hemendra J. Jones, Kelly A. |
AuthorAffiliation | 1 The Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and 3 McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA 5 Spinal Cord and Brain Injury Research Center, and 6 College of Public Health, University of Kentucky, Lexington, Kentucky, USA 2 Department of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA 4 Department of Neuroscience |
AuthorAffiliation_xml | – name: 3 McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA – name: 1 The Department of Internal Medicine, Division of Endocrinology, and the Barnstable Brown Diabetes and Obesity Center, and – name: 4 Department of Neuroscience – name: 5 Spinal Cord and Brain Injury Research Center, and – name: 6 College of Public Health, University of Kentucky, Lexington, Kentucky, USA – name: 2 Department of Rehabilitation Sciences, College of Health Sciences and Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA |
Author_xml | – sequence: 1 givenname: Brian S. surname: Finlin fullname: Finlin, Brian S. – sequence: 2 givenname: Hasiyet surname: Memetimin fullname: Memetimin, Hasiyet – sequence: 3 givenname: Amy L. surname: Confides fullname: Confides, Amy L. – sequence: 4 givenname: Ildiko surname: Kasza fullname: Kasza, Ildiko – sequence: 5 givenname: Beibei surname: Zhu fullname: Zhu, Beibei – sequence: 6 givenname: Hemendra J. surname: Vekaria fullname: Vekaria, Hemendra J. – sequence: 7 givenname: Brianna surname: Harfmann fullname: Harfmann, Brianna – sequence: 8 givenname: Kelly A. surname: Jones fullname: Jones, Kelly A. – sequence: 9 givenname: Zachary R. surname: Johnson fullname: Johnson, Zachary R. – sequence: 10 givenname: Philip M. surname: Westgate fullname: Westgate, Philip M. – sequence: 11 givenname: Caroline M. orcidid: 0000-0002-7830-8043 surname: Alexander fullname: Alexander, Caroline M. – sequence: 12 givenname: Patrick G. surname: Sullivan fullname: Sullivan, Patrick G. – sequence: 13 givenname: Esther E. surname: Dupont-Versteegden fullname: Dupont-Versteegden, Esther E. – sequence: 14 givenname: Philip A. surname: Kern fullname: Kern, Philip A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30089732$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UUtLAzEQDlKxtfYPeJA9emnNYx_ZiyBFrVDwoueQx-w2ZTepyVbw37ultVQPnmaY-R7DfJdo4LwDhK4JnhFS0Lu1tjProq1X3YxQkhF8hkaUFeWUFZgPTvohmsS4xhiTIqU44xdoyDDmZcHoCPHFtpUukcZufIREga2tqxPrkgBx410_63yifWMS6UzS2iAV1MG7K3ReySbC5FDH6P3p8W2-mC5fn1_mD8upTjHtpszkqswYVRnFZZrTTHOpqwqYwsDTvMoNZwpAKpNDvyYEG6NowbRJgVNWsjG63-tutqoFo8F1QTZiE2wrw5fw0orfG2dXovafIie0JGQncHsQCP5jC7ETrY0amkY68NsoKOY5zSkjrIfenHodTX7e1QPoHqCDjzFAdYQQLHaxiD4WcYhF7GPpSfwPSdtOdtbv7rXNf9RvgK2WrA |
CitedBy_id | crossref_primary_10_1186_s40246_019_0239_x crossref_primary_10_1074_jbc_REV119_007363 crossref_primary_10_1016_j_devcel_2022_11_007 crossref_primary_10_1016_j_lfs_2021_120229 crossref_primary_10_1016_j_heliyon_2022_e09128 crossref_primary_10_3390_metabo11050319 crossref_primary_10_1093_jmcb_mjaa029 crossref_primary_10_1097_MCO_0000000000000662 crossref_primary_10_1172_jci_insight_143650 crossref_primary_10_3390_ph14111196 crossref_primary_10_1210_clinem_dgz298 crossref_primary_10_1016_j_phrs_2023_106713 crossref_primary_10_7570_jomes20038 crossref_primary_10_3389_fendo_2022_898139 crossref_primary_10_1172_JCI134892 crossref_primary_10_1172_jci_insight_139160 crossref_primary_10_1177_23259671231170192 crossref_primary_10_3389_fphar_2024_1412520 crossref_primary_10_1016_j_stemcr_2021_01_013 crossref_primary_10_1038_s41467_023_38471_z crossref_primary_10_1016_j_ejphar_2022_174870 crossref_primary_10_1152_ajpcell_00060_2024 crossref_primary_10_1210_endrev_bnac015 crossref_primary_10_1002_smll_202002872 crossref_primary_10_1016_j_cmet_2022_09_009 crossref_primary_10_1080_23328940_2020_1769530 crossref_primary_10_1186_s12986_022_00694_0 crossref_primary_10_1042_BSR20194076 crossref_primary_10_3390_ijms23094880 crossref_primary_10_1002_oby_24132 crossref_primary_10_1016_j_biopha_2025_117838 crossref_primary_10_1016_j_cell_2020_06_021 crossref_primary_10_1074_jbc_RA119_011508 crossref_primary_10_1038_s41366_023_01270_z crossref_primary_10_1016_j_devcel_2021_02_018 crossref_primary_10_1172_JCI153357 crossref_primary_10_1249_MSS_0000000000003136 crossref_primary_10_3390_ijms252413295 crossref_primary_10_1002_mco2_207 crossref_primary_10_1172_JCI131126 crossref_primary_10_3390_nu12020472 crossref_primary_10_1007_s12272_021_01314_w crossref_primary_10_1111_bph_14631 crossref_primary_10_1016_j_cmet_2020_07_005 crossref_primary_10_1016_j_bbrc_2023_03_052 crossref_primary_10_1038_s41598_021_03014_3 crossref_primary_10_1016_j_biopha_2019_109439 crossref_primary_10_3390_molecules29102219 crossref_primary_10_3390_ijms23094759 crossref_primary_10_1016_j_jconrel_2024_09_025 crossref_primary_10_1097_SHK_0000000000001743 crossref_primary_10_1016_j_phrs_2020_105291 crossref_primary_10_1302_2046_3758_128_BJR_2022_0309_R2 crossref_primary_10_3389_fendo_2022_1037458 crossref_primary_10_1016_j_mam_2019_06_006 crossref_primary_10_1038_s43587_024_00633_z crossref_primary_10_1016_j_devcel_2024_03_012 crossref_primary_10_1016_j_mito_2021_05_001 crossref_primary_10_1093_function_zqac037 crossref_primary_10_1177_03000605221109391 crossref_primary_10_1007_s13679_024_00559_y crossref_primary_10_3390_metabo10110471 crossref_primary_10_4093_dmj_2023_0011 crossref_primary_10_1146_annurev_physiol_060721_092939 crossref_primary_10_3390_jcm12216897 crossref_primary_10_1038_s41598_019_45136_9 crossref_primary_10_1007_s00266_023_03782_5 crossref_primary_10_3389_jpps_2024_13157 crossref_primary_10_1186_s10020_020_00180_4 crossref_primary_10_1002_stem_3164 crossref_primary_10_1016_j_metabol_2025_156148 crossref_primary_10_1152_ajpendo_00259_2022 crossref_primary_10_18705_2782_3806_2025_5_1_6_28 crossref_primary_10_3389_fnins_2021_621356 crossref_primary_10_1093_cvr_cvac131 crossref_primary_10_1016_j_ando_2024_05_006 crossref_primary_10_3390_cells12060881 crossref_primary_10_2139_ssrn_4119814 crossref_primary_10_3389_fcell_2022_955612 crossref_primary_10_1073_pnas_1901655116 crossref_primary_10_1016_j_jep_2022_115700 crossref_primary_10_1038_s41467_024_46944_y crossref_primary_10_1093_asj_sjae070 crossref_primary_10_3389_fendo_2021_652444 crossref_primary_10_1016_j_phrs_2022_106634 crossref_primary_10_1002_mnfr_202000681 crossref_primary_10_1007_s42000_022_00361_2 crossref_primary_10_1001_jamacardio_2023_3003 crossref_primary_10_1096_fj_202101905RR crossref_primary_10_1371_journal_pbio_3002413 crossref_primary_10_1080_17512433_2023_2193681 crossref_primary_10_3390_biom14020159 crossref_primary_10_1016_j_molmet_2023_101683 crossref_primary_10_18632_aging_206203 crossref_primary_10_1002_oby_23496 crossref_primary_10_1111_apha_14127 crossref_primary_10_1016_j_devcel_2021_04_018 crossref_primary_10_1111_febs_15470 crossref_primary_10_1016_j_mmm_2021_10_017 crossref_primary_10_29219_fnr_v65_7577 crossref_primary_10_1530_JOE_18_0598 crossref_primary_10_3390_biom13121714 crossref_primary_10_3390_ijms22137050 crossref_primary_10_1002_mco2_70030 crossref_primary_10_1038_s41598_020_78419_7 crossref_primary_10_3390_ijms23031869 crossref_primary_10_1038_s42255_023_00837_4 crossref_primary_10_3390_cells9122584 crossref_primary_10_1038_s41574_020_0390_4 crossref_primary_10_1016_j_metabol_2024_155998 crossref_primary_10_1111_cpf_12896 crossref_primary_10_1113_JP280922 crossref_primary_10_1038_s41580_021_00350_0 crossref_primary_10_3389_fphys_2023_1132830 crossref_primary_10_1152_ajpendo_00310_2020 crossref_primary_10_1016_j_mam_2019_07_001 crossref_primary_10_1042_CS20190522 crossref_primary_10_3390_cancers14081948 crossref_primary_10_1016_j_biopha_2021_111491 crossref_primary_10_5534_wjmh_220224 crossref_primary_10_1111_dom_15781 crossref_primary_10_1161_ATVBAHA_121_315882 crossref_primary_10_1038_s41598_020_64369_7 crossref_primary_10_3389_fped_2024_1401737 crossref_primary_10_1002_ctm2_1108 crossref_primary_10_3389_fendo_2019_00368 crossref_primary_10_1007_s10522_024_10137_3 crossref_primary_10_1016_j_hsr_2024_100148 crossref_primary_10_1124_jpet_118_255778 crossref_primary_10_3389_fendo_2020_00222 crossref_primary_10_1111_1440_1681_13566 crossref_primary_10_3389_fphys_2020_00749 crossref_primary_10_1073_pnas_2205626119 crossref_primary_10_2217_epi_2023_0381 crossref_primary_10_1080_27697061_2023_2280777 crossref_primary_10_1002_mco2_752 crossref_primary_10_33549_physiolres_935361 crossref_primary_10_1016_j_gene_2024_148421 |
Cites_doi | 10.2337/db09-0530 10.1007/s00192-013-2042-x 10.1155/2015/341583 10.1002/ana.20062 10.1038/nm.4031 10.3389/fendo.2015.00156 10.1016/j.cell.2013.12.021 10.1152/japplphysiol.00096.2017 10.1016/j.cmet.2011.06.012 10.1016/S2213-8587(14)70033-6 10.1172/JCI62308 10.1074/jbc.M305235200 10.1210/js.2017-00202 10.1016/0895-7061(96)87747-8 10.1038/ijo.2013.206 10.1016/j.cmet.2012.01.004 10.1016/j.cmet.2016.10.023 10.1016/j.bbalip.2013.02.005 10.1038/oby.2011.125 10.1016/j.tem.2012.06.004 10.1016/j.tips.2013.04.004 10.1080/21623945.2016.1191307 10.1016/j.cmet.2008.12.014 10.1089/neu.2006.3673 10.1038/366740a0 10.1172/JCI60433 10.1172/JCI78362 10.1038/nature17399 10.1002/ana.10543 10.1152/ajpendo.00298.2010 10.1210/jc.2006-1740 10.1016/j.molmet.2015.07.001 10.1016/j.cmet.2013.02.020 10.1056/NEJMoa0808718 10.1152/ajpendo.00329.2010 10.1074/jbc.M115.637785 10.1111/ijcp.12433 10.1016/0026-0495(89)90118-2 10.1016/j.cmet.2015.06.022 10.1016/j.cmet.2014.12.009 10.2337/diabetes.47.10.1555 10.2337/db14-0746 10.1038/nature13528 10.1016/j.cell.2012.05.016 10.1038/nm.3891 10.1152/ajpendo.00284.2016 10.1016/0076-6879(79)55010-1 10.2337/diabetes.54.8.2305 10.1016/S0014-2999(02)01421-8 10.1073/pnas.1310261110 10.1016/j.ecl.2004.03.002 10.1016/j.cmet.2015.09.007 10.1056/NEJMoa0810780 10.2337/db10-0004 10.1038/281031a0 10.1210/jc.2014-2440 10.1113/expphysiol.2014.081414 10.1128/MCB.24.7.3057-3067.2004 10.2337/db16-1057 10.1073/pnas.1207287109 10.1016/j.cmet.2014.06.011 |
ContentType | Journal Article |
Copyright | Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation |
Copyright_xml | – notice: Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1172/jci.insight.121510 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2379-3708 |
ExternalDocumentID | PMC6129119 30089732 10_1172_jci_insight_121510 |
Genre | Video-Audio Media Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation | NIH (DK107646, DK112282, P20GM103527, and by CTSA grant UL1TR001998). |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: P30 GM127211 – fundername: NIGMS NIH HHS grantid: P20 GM103527 – fundername: NIDDK NIH HHS grantid: R01 DK112282 – fundername: NCATS NIH HHS grantid: UL1 TR001998 – fundername: NIDDK NIH HHS grantid: R01 DK107646 |
GroupedDBID | 53G AAFWJ AAYXX ADBBV AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS CITATION GROUPED_DOAJ HYE M~E OK1 RPM CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c402t-3d6b9532b52094625c8acffe3b0e846f6d83beeabd6e462110ddb273cd4e82393 |
ISSN | 2379-3708 |
IngestDate | Thu Aug 21 13:27:40 EDT 2025 Fri Jul 11 06:47:14 EDT 2025 Thu Jan 02 22:59:36 EST 2025 Tue Jul 01 02:59:22 EDT 2025 Thu Apr 24 23:08:05 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Keywords | Obesity Adipose tissue Metabolism Clinical Trials |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c402t-3d6b9532b52094625c8acffe3b0e846f6d83beeabd6e462110ddb273cd4e82393 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Authorship note: BSF, HM, and ALC contributed equally to this work. |
ORCID | 0000-0002-7830-8043 |
OpenAccessLink | http://insight.jci.org/articles/view/121510/files/pdf |
PMID | 30089732 |
PQID | 2086262313 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6129119 proquest_miscellaneous_2086262313 pubmed_primary_30089732 crossref_primary_10_1172_jci_insight_121510 crossref_citationtrail_10_1172_jci_insight_121510 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-8-9 2018-08-09 20180809 |
PublicationDateYYYYMMDD | 2018-08-09 |
PublicationDate_xml | – month: 08 year: 2018 text: 2018-8-9 day: 09 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JCI insight |
PublicationTitleAlternate | JCI Insight |
PublicationYear | 2018 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | B20 B21 B22 B23 B24 B25 B27 B28 B29 Thorp (B36) 2015; 2015 B30 B31 B32 B33 B34 Cannon (B58) 1979; 55 B35 B37 B39 B1 B2 B3 B4 B5 B6 Porter (B7) 2015; 6 B8 B9 Frontini (B26) 2013; 1831 B40 B41 B42 B43 B44 B45 B46 B47 B48 B49 Facchini (B38) 1996; 9 B50 B51 B52 B53 B10 B54 B11 B55 B12 B56 B13 B57 B14 B15 B59 B16 B17 B18 B19 B60 B61 |
References_xml | – ident: B22 doi: 10.2337/db09-0530 – ident: B54 doi: 10.1007/s00192-013-2042-x – volume: 2015 year: 2015 ident: B36 article-title: Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome publication-title: J Diabetes Res doi: 10.1155/2015/341583 – ident: B61 doi: 10.1002/ana.20062 – ident: B15 doi: 10.1038/nm.4031 – volume: 6 year: 2015 ident: B7 article-title: The Therapeutic Potential of Brown Adipocytes in Humans publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2015.00156 – ident: B9 doi: 10.1016/j.cell.2013.12.021 – ident: B32 doi: 10.1152/japplphysiol.00096.2017 – ident: B11 doi: 10.1016/j.cmet.2011.06.012 – ident: B35 doi: 10.1016/S2213-8587(14)70033-6 – ident: B8 doi: 10.1172/JCI62308 – ident: B29 doi: 10.1074/jbc.M305235200 – ident: B57 doi: 10.1210/js.2017-00202 – volume: 9 start-page: 1013 issue: 10 Pt 1 year: 1996 ident: B38 article-title: Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate publication-title: Am J Hypertens doi: 10.1016/0895-7061(96)87747-8 – ident: B12 doi: 10.1038/ijo.2013.206 – ident: B16 doi: 10.1016/j.cmet.2012.01.004 – ident: B42 doi: 10.1016/j.cmet.2016.10.023 – volume: 1831 start-page: 950 issue: 5 year: 2013 ident: B26 article-title: White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma publication-title: Biochim Biophys Acta doi: 10.1016/j.bbalip.2013.02.005 – ident: B40 doi: 10.1038/oby.2011.125 – ident: B45 doi: 10.1016/j.tem.2012.06.004 – ident: B49 doi: 10.1016/j.tips.2013.04.004 – ident: B23 doi: 10.1080/21623945.2016.1191307 – ident: B6 doi: 10.1016/j.cmet.2008.12.014 – ident: B59 doi: 10.1089/neu.2006.3673 – ident: B5 doi: 10.1038/366740a0 – ident: B13 doi: 10.1172/JCI60433 – ident: B3 doi: 10.1172/JCI78362 – ident: B43 doi: 10.1038/nature17399 – ident: B60 doi: 10.1002/ana.10543 – ident: B14 doi: 10.1152/ajpendo.00298.2010 – ident: B50 doi: 10.1210/jc.2006-1740 – ident: B47 doi: 10.1016/j.molmet.2015.07.001 – ident: B48 doi: 10.1016/j.cmet.2013.02.020 – ident: B21 doi: 10.1056/NEJMoa0808718 – ident: B55 doi: 10.1152/ajpendo.00329.2010 – ident: B34 doi: 10.1074/jbc.M115.637785 – ident: B53 doi: 10.1111/ijcp.12433 – ident: B39 doi: 10.1016/0026-0495(89)90118-2 – ident: B24 doi: 10.1016/j.cmet.2015.06.022 – ident: B28 doi: 10.1016/j.cmet.2014.12.009 – ident: B52 doi: 10.2337/diabetes.47.10.1555 – ident: B10 doi: 10.2337/db14-0746 – ident: B27 doi: 10.1038/nature13528 – ident: B2 doi: 10.1016/j.cell.2012.05.016 – ident: B17 doi: 10.1038/nm.3891 – ident: B44 doi: 10.1152/ajpendo.00284.2016 – volume: 55 start-page: 65 year: 1979 ident: B58 article-title: Mitochondria from brown adipose tissue: isolation and properties publication-title: Meth Enzymol doi: 10.1016/0076-6879(79)55010-1 – ident: B56 doi: 10.2337/diabetes.54.8.2305 – ident: B51 doi: 10.1016/S0014-2999(02)01421-8 – ident: B33 doi: 10.1073/pnas.1310261110 – ident: B37 doi: 10.1016/j.ecl.2004.03.002 – ident: B1 doi: 10.1016/j.cmet.2015.09.007 – ident: B20 doi: 10.1056/NEJMoa0810780 – ident: B41 doi: 10.2337/db10-0004 – ident: B4 doi: 10.1038/281031a0 – ident: B19 doi: 10.1210/jc.2014-2440 – ident: B46 doi: 10.1113/expphysiol.2014.081414 – ident: B31 doi: 10.1128/MCB.24.7.3057-3067.2004 – ident: B18 doi: 10.2337/db16-1057 – ident: B30 doi: 10.1073/pnas.1207287109 – ident: B25 doi: 10.1016/j.cmet.2014.06.011 |
SSID | ssj0001742058 |
Score | 2.4590836 |
Snippet | The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in obesity. The... BACKGROUND. The induction of beige adipocytes in s.c. white adipose tissue (WAT) depots of humans is postulated to improve glucose and lipid metabolism in... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Acetanilides - pharmacology Acetanilides - therapeutic use Adipose Tissue, Beige - drug effects Adipose Tissue, Beige - metabolism Adipose Tissue, Beige - pathology Adrenergic beta-3 Receptor Agonists - pharmacology Adrenergic beta-3 Receptor Agonists - therapeutic use Adult Biopsy Clinical Medicine Cold Temperature - adverse effects Energy Metabolism - drug effects Energy Metabolism - physiology Female Humans Lipid Metabolism - drug effects Lipid Metabolism - physiology Male Membrane Proteins - metabolism Middle Aged Obesity - drug therapy Obesity - metabolism Obesity - pathology Subcutaneous Fat - drug effects Subcutaneous Fat - metabolism Subcutaneous Fat - pathology Thermogenesis - physiology Thiazoles - pharmacology Thiazoles - therapeutic use Uncoupling Protein 1 - metabolism |
Title | Human adipose beiging in response to cold and mirabegron |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30089732 https://www.proquest.com/docview/2086262313 https://pubmed.ncbi.nlm.nih.gov/PMC6129119 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFLc6dtllGtpXGUyetFuVLrGdjx4RYoIxdgKJW-SvMG80RW16gAN_O8-O46bQTWOXqHJiy_Xv5fn3nPeB0Oc0kVSxjEYyjRkYKDqPBEt4RCSpiKoSnlAb73z6Izs6Z98u0ovB4KTntbRsxFjebowr-R9UoQ1wtVGyT0A2DAoN8BvwhSsgDNd_wrg9gefKXFuvc6HNZYhQcZ6vriwGIO3SsY6mZs6Fvpx7IDpGenBsHdKtjR6wNHVXxn3u3v9xgEVPdWPrgLkdiy_MzSp-2sYOGtVqnf3pzeh76HXCF7eOox5fKfN71j9oSArn5jZZ6SNC8wnoo7hVl3pDm1eotC836WY9ndu8r7-kGft_6LJceAfXtaTYDzar4ELojJeclDBG6cco2zGeoecEbAZbzuL0rnfgljMSu3qtYdJdEFVOvjyeyjpReWR9PHSi7bGSs1fopTcn8H4rG9tooOvXqHBygb1cYC8X2NS4kwvczLCVCwxygVdy8Qadfz08OziKfIWMSILd30RUZWKSUiKsMxMDU1YWXFaVpiLWQCyrTBVUaM2FyjTcBqqnlADCKhXThU1-9xZt1bNav0e4YtCBFyJWccGgC2d5JbTimUiKXKt4iJJuOUrp08fbKiZX5Z-RGKJR6HPdJk_569OfulUuQcfZD1e81rPloiTO7gZLhA7Ru3bVw3gUSKzNODVE-Roe4QGbP339Tm1-ujzqQO5hq5_sPGmWH9CL1cuxi7aa-VLvAS9txEcnb_dY8pKB |
linkProvider | ISSN International Centre |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+adipose+beiging+in+response+to+cold+and+mirabegron&rft.jtitle=JCI+insight&rft.au=Finlin%2C+Brian+S.&rft.au=Memetimin%2C+Hasiyet&rft.au=Confides%2C+Amy+L.&rft.au=Kasza%2C+Ildiko&rft.date=2018-08-09&rft.issn=2379-3708&rft.eissn=2379-3708&rft.volume=3&rft.issue=15&rft_id=info:doi/10.1172%2Fjci.insight.121510&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_jci_insight_121510 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2379-3708&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2379-3708&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2379-3708&client=summon |